Results 1 to 10 of about 19,360,572 (149)

Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery [PDF]

Frontiers in Cardiovascular Medicine
BackgroundRecent studies demonstrated satisfactory results of del Nido cardioplegia in minimally invasive cardiac surgery (MICS). We aimed to evaluate the efficacy of our modified “bloodless” del Nido cardioplegia in MICS compared to the histidine ...
Heemoon Lee, Jihoon Kim, Jae Suk Yoo
doaj   +4 more sources

Comparison of routine del Nido cardioplegia vs two types of modified del Nido cardioplegias for myocardial protection among patients undergoing coronary artery bypass grafting (CABG) surgeries: A randomized double-blind clinical trial [PDF]

The Journal of ExtraCorporeal Technology
Background: The del Nido cardioplegia solution is a widely used method for myocardial protection in various settings. However, there is limited evidence of its effectiveness in adult cardiac surgery, and the baseline solution, Plasma Lyte A, is not ...
Ali Babar, Butt Salman Pervaiz, Nour Mohammad Ghazi, Khosravi Mohammad Bagher, Asmarian Naeimehossadat, Shoul Ali Raza, Kumar Arun, Darr Umer, Bhatnagar Gopal   +8 more
doaj   +3 more sources

Modified Del Nido Cardioplegia with a 1:4 Crystalloid-to-Blood Ratio Versus Blood-Based St. Thomas Cardioplegia in Isolated Aortic Valve Replacement [PDF]

Journal of Cardiovascular Development and Disease
The aim of this study was to retrospectively compare modified Del Nido and blood-based St. Thomas cardioplegia in adult patients undergoing isolated aortic valve replacement (AVR).
Peter Jakub, Tomáš Toporcer, Matúš Marcin, Michal Trebišovský, Anton Bereš, Marián Homola, Štefan Lukačín, Adrián Kolesár   +7 more
doaj   +2 more sources

Comparison of del Nido and blood cardioplegia on metabolic changes and acid–base balance in adult cardiac surgeries under cardiopulmonary bypass [PDF]

Indian Journal of Anaesthesia
Background and Aims: del Nido cardioplegia (DC), initially developed for paediatric cardiac surgery, is increasingly used in adult procedures due to its ability to provide prolonged myocardial protection with a single dose.
Prashanth Chintalapudi, Syama Sundar Ayya, Akhya Kumar Kar, Dintakurthi Ragha Renuka, Gopinath Ramachandran, Praveena Anyapu   +5 more
doaj   +2 more sources

Modified Del Nido Versus Custodiol® Cardioplegia for Myocardial Protection in Adult Patients Undergoing Cardiac Surgery; A Prospective Randomized Double-Blinded Clinical Trial [PDF]

Annals of Cardiac Anaesthesia
Background: Cardioplegia is essential for myocardial protection. Modified Del Nido and Custodiol® cardioplegia have been successfully used; however, a limited number of clinical trials compared both solutions.
Mahdy A. Abdelhady, Abeer S. Goda, Mohamed S. Sayed Gomaa, Mohamed A. Hamed, Alyaa A. S. Mohammed Hassan   +4 more
doaj   +2 more sources

The efficacy of modified bloodless del Nido cardioplegia in isolated aortic valve replacement. [PDF]

PLoS ONE
This study aimed to evaluate the safety and efficacy of a modified, bloodless Del Nido (DN) cardioplegia solution in patients undergoing isolated aortic valve replacement (AVR).
Bongyeon Sohn, Jae Suk Yoo, Dong Jin Kim, Heemoon Lee   +3 more
doaj   +2 more sources

Cerebral Inflammation in an Animal Ischemia–Reperfusion Model Comparing Histidine-Tryptophan-α-Ketoglutarate and Del Nido Cardioplegia [PDF]

Life
Brain injury and cerebral inflammation are frequent complications following cardiopulmonary bypass (CPB) resulting in neurocognitive dysfunction, encephalopathy, or stroke.
Kristin Klaeske, Maja-Theresa Dieterlen, Jagdip Kang, Zoe Detzer, André Ginther, Susann Ossmann, Michael A. Borger, Philipp Kiefer, Alexandro A. Hoyer   +8 more
doaj   +2 more sources

Traditional vs. modified Ringer lactate-based del Nido cardioplegia impacts on clinical outcomes in patients undergoing coronary artery bypass grafting: Results from a prospective, randomized, blinded trial [PDF]

The Journal of ExtraCorporeal Technology
Introduction: Myocardial protection with cardioplegia is a crucial approach to mitigate myocardial damage during coronary bypass grafting surgery (CABG) with cardiopulmonary bypass (CPB).
Kachoueian Naser, Janghorban Salimeh, Gorjipour Farhad, Torkashvand Majid, Mahjoob Mohammad Parsa, Aslani Hossein, Mehrabanian Mohamadjavad, Gorjipour Fazel   +7 more
doaj   +2 more sources

del Nido versus St. Thomas’ blood cardioplegia in the young (DESTINY) trial: protocol for a multicentre randomised controlled trial in children undergoing cardiac surgery [PDF]

BMJ Open
Introduction Myocardial protection against ischaemia–reperfusion injury is a key determinant of heart function and outcome following cardiac surgery in children.
Massimo Caputo, Serban Stoica, Kelly Handley, Timothy J Jones, Nigel E Drury, Barnaby R Scholefield, Martin Kostolny, Alex Robertson, Yongzhong Sun, Carin Van Doorn, Warwick B Dunn, John V Pappachan, Hugh Jarrett, Carly Tooke, Tina Griffin, Indie Bilkhoo   +15 more
doaj   +2 more sources

Comparison of Del Nido and histidine-tryptophan-ketoglutarate cardioplegia solutions: an animal study with prolonged ischaemia

Frontiers in Cardiovascular Medicine
ObjectiveMyocardial protection is important for a successful procedure cardiac surgery, and the key element of myocardial protection is cardioplegia. We compared Del Nido cardioplegia (DN) and Bretschneider histidine-tryptophan-ketoglutarate cardioplegia
Alexandro Hoyer, Maja-Theresa Dieterlen, Jagdip Kang, Hanna Oetzel, Karoline Wiesner, Kristin Klaeske, Philipp Kiefer, Susann Oßmann, André Ginther, Martin Kostelka, Suzanne de Waha, Michael A. Borger   +11 more
doaj   +3 more sources